Solanum incanum extract (also known as SR-T100), has been shown to downregulate c/EBPβ and COL11A1 expression, thereby sensitizing melanoma and ovarian cancer cells to cisplatin [101]. The gene discussed is COL11A1; the disease is ovarian carcinoma.